| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |